BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12899722)

  • 21. Features and outcomes of malaria infection in glucose-6-phosphatedehydrogenase normal and deficient Nigerian children.
    Orimadegun AE; Sodeinde O
    J Vector Borne Dis; 2014 Mar; 51(1):33-9. PubMed ID: 24717200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients.
    Kotepui M; Uthaisar K; PhunPhuech B; Phiwklam N
    Infect Dis Poverty; 2016 Apr; 5():36. PubMed ID: 27109515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes.
    Miller J; Golenser J; Spira DT; Kosower NS
    Exp Parasitol; 1984 Jun; 57(3):239-47. PubMed ID: 6373352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane protein carbonylation of Plasmodium falciparum infected erythrocytes under conditions of sickle cell trait and G6PD deficiency.
    Contreras-Puentes N; Rodríguez-Cavallo E; Méndez-Cuadro D
    Mol Biochem Parasitol; 2019 Jan; 227():5-14. PubMed ID: 30472238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fluorometric assay to determine the protective effect of glucose-6-phosphate dehydrogenase (G6PD) against a Plasmodium spp. infection in females heterozygous for the G6PD gene: proof of concept in Plasmodium falciparum.
    Rumaseb A; Marfurt J; Kho S; Kahn M; Price RN; Ley B
    BMC Res Notes; 2022 Feb; 15(1):76. PubMed ID: 35193663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro.
    Preuss J; Maloney P; Peddibhotla S; Hedrick MP; Hershberger P; Gosalia P; Milewski M; Li YL; Sugarman E; Hood B; Suyama E; Nguyen K; Vasile S; Sergienko E; Mangravita-Novo A; Vicchiarelli M; McAnally D; Smith LH; Roth GP; Diwan J; Chung TD; Jortzik E; Rahlfs S; Becker K; Pinkerton AB; Bode L
    J Med Chem; 2012 Aug; 55(16):7262-72. PubMed ID: 22813531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophils and monocytes from subjects with the Mediterranean G6PD variant: effect of Plasmodium falciparum hemozoin on G6PD activity, oxidative burst and cytokine production.
    Mordmüller B; Turrini F; Long H; Kremsner PG; Arese P
    Eur Cytokine Netw; 1998 Sep; 9(3):239-45. PubMed ID: 9831172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians.
    Louicharoen C; Patin E; Paul R; Nuchprayoon I; Witoonpanich B; Peerapittayamongkol C; Casademont I; Sura T; Laird NM; Singhasivanon P; Quintana-Murci L; Sakuntabhai A
    Science; 2009 Dec; 326(5959):1546-9. PubMed ID: 20007901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The adaptation of Plasmodium falciparum to oxidative stress in G6PD deficient human erythrocytes.
    Roth E; Schulman S
    Br J Haematol; 1988 Nov; 70(3):363-7. PubMed ID: 3061444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel glucose-6-phosphate dehydrogenase in Plasmodium falciparum: cDNA and primary protein structure.
    Shahabuddin M; Rawlings DJ; Kaslow DC
    Biochim Biophys Acta; 1994 Sep; 1219(1):191-4. PubMed ID: 8086463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in the host and adaptive phenomena in Plasmodium falciparum infection.
    Luzzatto L; Sodeinde O; Martini G
    Ciba Found Symp; 1983; 94():159-73. PubMed ID: 6341000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-6-phosphate metabolism in Plasmodium falciparum.
    Preuss J; Jortzik E; Becker K
    IUBMB Life; 2012 Jul; 64(7):603-11. PubMed ID: 22639416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the intraerythrocytic development of Plasmodium falciparum in glucose-6-phosphate dehydrogenase deficient erythrocytes is enhanced by oxidants and by crisis form factor.
    Golenser J; Miller J; Spira DT; Kosower NS; Vande Waa JA; Jensen JB
    Trop Med Parasitol; 1988 Dec; 39(4):273-6. PubMed ID: 3067318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on glucose-6-phosphate dehydrogenase deficiency in children from Brazzaville, Republic of Congo.
    Gampio Gueye NS; Peko SM; Nderu D; Koukouikila-Koussounda F; Vouvoungui C; Kobawila SC; Velavan TP; Ntoumi F
    Malar J; 2019 Feb; 18(1):57. PubMed ID: 30819192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-ordinated stage-dependent enhancement of Plasmodium falciparum antioxidant enzymes and heat shock protein expression in parasites growing in oxidatively stressed or G6PD-deficient red blood cells.
    Akide-Ndunge OB; Tambini E; Giribaldi G; McMillan PJ; Müller S; Arese P; Turrini F
    Malar J; 2009 May; 8():113. PubMed ID: 19480682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red cell glucose-6-phosphate dehydrogenase status and pyruvate kinase activity in a Nigerian population.
    May J; Meyer CG; Grossterlinden L; Ademowo OG; Mockenhaupt FP; Olumese PE; Falusi AG; Luzzatto L; Bienzle U
    Trop Med Int Health; 2000 Feb; 5(2):119-23. PubMed ID: 10747271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relating mutant genotype to phenotype via quantitative behavior of the NADPH redox cycle in human erythrocytes.
    Coelho PM; Salvador A; Savageau MA
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria.
    Guindo A; Fairhurst RM; Doumbo OK; Wellems TE; Diallo DA
    PLoS Med; 2007 Mar; 4(3):e66. PubMed ID: 17355169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-Phosphogluconolactonase.
    Berneburg I; Peddibhotla S; Heimsch KC; Haeussler K; Maloney P; Gosalia P; Preuss J; Rahbari M; Skorokhod O; Valente E; Ulliers D; Simula LF; Buchholz K; Hedrick MP; Hershberger P; Chung TDY; Jackson MR; Schwarzer E; Rahlfs S; Bode L; Becker K; Pinkerton AB
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0210921. PubMed ID: 35266827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing the Fused TvG6PD::6PGL Protein from the Protozoan
    Morales-Luna L; Hernández-Ochoa B; Ramírez-Nava EJ; Martínez-Rosas V; Ortiz-Ramírez P; Fernández-Rosario F; González-Valdez A; Cárdenas-Rodríguez N; Serrano-Posada H; Centeno-Leija S; Arreguin-Espinosa R; Cuevas-Cruz M; Ortega-Cuellar D; Pérez de la Cruz V; Rocha-Ramírez LM; Sierra-Palacios E; Castillo-Rodríguez RA; Vega-García V; Rufino-González Y; Marcial-Quino J; Gómez-Manzo S
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.